Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Saved in:
| Main Authors: | , , |
|---|---|
| Other Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2014
|
| In: |
The lancet. Oncology
Year: 2014, Volume: 15, Issue: 7, Pages: 747-756 |
| ISSN: | 1474-5488 |
| DOI: | 10.1016/S1470-2045(14)70160-3 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S1470-2045(14)70160-3 |
| Author Notes: | Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Costa, Hans Tesch, Claus Hanusch, Jörn Hilfrich, Fariba Khandan, Peter A Fasching, Bruno V Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 1474-5488 |
| DOI: | 10.1016/S1470-2045(14)70160-3 |